MedTrace Logo

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

NCT01741311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2025-08-08

Study results available
· View outcomes & findings →

Summary

This study will test whether 3H+ (Holistic Health for HIV) is comparable to the original HHRP+ (Holistic Health Recovery Program) in reducing HIV risk behaviors and improving ART (Antiretroviral Therapy) adherence in a randomized controlled comparative effectiveness trial among 256 HIV+ persons in drug treatment who report unsafe injection drug use practices or sexual risk behavior.

Conditions

  • Risk Behavior
  • Medication Adherence
  • HIV

Interventions

BEHAVIORAL

3H+ (Holistic Health for HIV)

Four weekly HIV-risk reduction groups and an additional booster group held at week twelve summarizing the previous sessions' content, designed for opioid-dependent individuals living with HIV.

BEHAVIORAL

HHRP+ (Holistic Health Recovery Program)

12 two-hour group sessions addressing HIV risk reduction behavior and recovery for opioid-dependent individuals living with HIV.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    collaborator OTHER

  • APT Foundation, Inc.

    collaborator OTHER

  • University of Connecticut

    lead OTHER

Principal Investigators

  • Michael C Copenhaver, Ph.D. · University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741311 on ClinicalTrials.gov